Literature DB >> 12059784

Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells.

Takanori Kitamura1, Kazuhiro Kimura, Bae Dong Jung, Kennedy Makondo, Naoki Sakane, Toshihide Yoshida, Masayuki Saito.   

Abstract

Proinsulin C-peptide has been reported to have some biological activities and to be possibly involved in the development of diabetic microangiopathy. In the present study, we examined the effects of C-peptide on the mitogen-activated protein kinase pathway in LEII mouse lung capillary endothelial cells. Stimulation of the cells with C-peptide increased both p38 mitogen-activated protein kinase (p38MAPK) and extracellular signal-regulated kinase (ERK1/2) activities and activity-related site-specific phosphorylation of the respective kinases in a concentration-dependent manner, but failed to activate c-Jun N-terminal kinase. Stimulation of the cells with C-peptide also induced site-specific phosphorylation of cAMP response element (CRE)-binding protein (CREB)/activating transcription factor 1 (ATF1), and thereby binding of these transcription factors to CRE. Among three CREB kinases tested, phosphorylation of mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) was induced after stimulation with C-peptide. The phosphorylation of CREB, ATF1 and MAPKAP-K2 were inhibited by SB203580, a p38MAPK inhibitor, but not by PD98059, an ERK kinase inhibitor. These results indicate that C-peptide activates p38MAPK followed by MAPKAP-K2 to enhance DNA-CREB/ATF1 interactions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12059784      PMCID: PMC1222821          DOI: 10.1042/BJ20020344

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation.

Authors:  J R Zierath; A Handberg; M Tally; H Wallberg-Henriksson
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

2.  FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2.

Authors:  Y Tan; J Rouse; A Zhang; S Cariati; P Cohen; M J Comb
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

3.  C-peptide improves autonomic nerve function in IDDM patients.

Authors:  B L Johansson; K Borg; E Fernqvist-Forbes; T Odergren; S Remahl; J Wahren
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

4.  Neurotransmitter- and growth factor-induced cAMP response element binding protein phosphorylation in glial cell progenitors: role of calcium ions, protein kinase C, and mitogen-activated protein kinase/ribosomal S6 kinase pathway.

Authors:  M Pende; T L Fisher; P B Simpson; J T Russell; J Blenis; V Gallo
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

5.  Effect of C-peptide administration on whole body glucose utilization in STZ-induced diabetic rats.

Authors:  W Wu; Y Oshida; W P Yang; L Li; I Ohsawa; J Sato; S Iwao; B L Johansson; J Wahren; Y Sato
Journal:  Acta Physiol Scand       Date:  1996-06

6.  CREB is a regulatory target for the protein kinase Akt/PKB.

Authors:  K Du; M Montminy
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

7.  Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1.

Authors:  B L Johansson; A Kernell; S Sjöberg; J Wahren
Journal:  J Clin Endocrinol Metab       Date:  1993-10       Impact factor: 5.958

8.  Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1 (insulin-dependent) diabetic patients.

Authors:  B L Johansson; B Linde; J Wahren
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

9.  Transcription factor ATF2 regulation by the JNK signal transduction pathway.

Authors:  S Gupta; D Campbell; B Dérijard; R J Davis
Journal:  Science       Date:  1995-01-20       Impact factor: 47.728

10.  Prolonged plasma half-life of insulin in patients with a genetic defect of high affinity binding sites.

Authors:  M Dreyer; S Matthaei; J Kühnau; H W Rüdiger
Journal:  Horm Metab Res       Date:  1986-04       Impact factor: 2.936

View more
  19 in total

Review 1.  An update on the potential role of C-peptide in diabetes and osteoporosis.

Authors:  Arturo Pujia; Carmine Gazzaruso; Tiziana Montalcini
Journal:  Endocrine       Date:  2017-04-03       Impact factor: 3.633

2.  C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells.

Authors:  Z Zhong; A Davidescu; I Ehrén; K Ekberg; H Jörnvall; J Wahren; A V Chibalin
Journal:  Diabetologia       Date:  2004-12-29       Impact factor: 10.122

Review 3.  Advanced glycation end products and C-peptide-modulators in diabetic vasculopathy and atherogenesis.

Authors:  Daniel Walcher; Nikolaus Marx
Journal:  Semin Immunopathol       Date:  2009-04-05       Impact factor: 9.623

4.  Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats.

Authors:  T Kitamura; K Kimura; K Makondo; D T Furuya; M Suzuki; T Yoshida; M Saito
Journal:  Diabetologia       Date:  2003-10-30       Impact factor: 10.122

5.  C-Peptide and its intracellular signaling.

Authors:  Claire E Hills; Nigel J Brunskill
Journal:  Rev Diabet Stud       Date:  2009-11-10

6.  Molecular effects of C-Peptide in microvascular blood flow regulation.

Authors:  Thomas Forst; Thomas Hach; Thomas Kunt; Matthias M Weber; Andreas Pfützner
Journal:  Rev Diabet Stud       Date:  2009-11-10

7.  C-Peptide in the vessel wall.

Authors:  Daniel Walcher; Nikolaus Marx
Journal:  Rev Diabet Stud       Date:  2009-11-10

8.  Proinflammatory effects of C-Peptide in different tissues.

Authors:  Dusica Vasic; Daniel Walcher
Journal:  Int J Inflam       Date:  2012-06-11

9.  C-Peptide reduces mitochondrial superoxide generation by restoring complex I activity in high glucose-exposed renal microvascular endothelial cells.

Authors:  Himani Vejandla; John M Hollander; Anand Kothur; Robert W Brock
Journal:  ISRN Endocrinol       Date:  2012-06-21

10.  Renal and vascular benefits of C-peptide: Molecular mechanisms of C-peptide action.

Authors:  Lina Nordquist; Fredrik Palm; Bradley T Andresen
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.